Figure 6 . (A) 3D binding mode and overlay of Pazopanib and the designed compounds in kinase domain of human VEGFR-2 (PDB 3EWH). 2D of ligand receptor interaction of (B) Benzimidazotriazine, (C) Benzoimidazoquinazoline, and (D) Pazopanib